Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505. Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 1 Marion Danis, MD Virtual Mentor. 2004;6(1):6-8. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401. Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 2 Leonard M. Fleck, PhD Virtual Mentor. 2004;6(1):9-11. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401. In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102. Policy Forum Nov 2016 Transgender Reproductive Choice and Fertility Preservation Khadija Mitu, PhD Transgender people planning a medical transition face decisions about family planning, fertility preservation, and how to access gender-affirming treatment. AMA J Ethics. 2016;18(11):1119-1125. doi: 10.1001/journalofethics.2016.18.11.pfor2-1611. Health Law Aug 2010 The LGBT Community, Health Policy, and the Law Ryan Bailey Virtual Mentor. 2010;12(8):658-662. doi: 10.1001/virtualmentor.2010.12.8.hlaw1-1008.
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.
Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 1 Marion Danis, MD Virtual Mentor. 2004;6(1):6-8. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401.
Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 2 Leonard M. Fleck, PhD Virtual Mentor. 2004;6(1):9-11. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401.
In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102.
Policy Forum Nov 2016 Transgender Reproductive Choice and Fertility Preservation Khadija Mitu, PhD Transgender people planning a medical transition face decisions about family planning, fertility preservation, and how to access gender-affirming treatment. AMA J Ethics. 2016;18(11):1119-1125. doi: 10.1001/journalofethics.2016.18.11.pfor2-1611.
Health Law Aug 2010 The LGBT Community, Health Policy, and the Law Ryan Bailey Virtual Mentor. 2010;12(8):658-662. doi: 10.1001/virtualmentor.2010.12.8.hlaw1-1008.